Targeting acute myeloid leukemia using sphingosine kinase 1 inhibitor-loaded liposomes

TM Nguyen, M Jambhrunkar, SS Wong… - Molecular …, 2023 - ACS Publications
Acute myeloid leukemia (AML) kills 75% of patients and represents a major clinical
challenge with a need to improve on current treatment approaches. Targeting sphingosine …
被引用次数：5 相关文章

Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes

TM Nguyen, M Jambhrunkar… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) kills 75% of patients and represents a major clinical
challenge with a need to improve on current treatment approaches. Targeting sphingosine …

Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes.

TM Nguyen, M Jambhrunkar, SS Wong… - Molecular …, 2023 - europepmc.org
Acute myeloid leukemia (AML) kills 75% of patients and represents a major clinical
challenge with a need to improve on current treatment approaches. Targeting sphingosine …

Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes

TM Nguyen, M Jambhrunkar… - Molecular …, 2023 - researchnow.flinders.edu.au
Acute myeloid leukemia (AML) kills 75% of patients and represents a major clinical
challenge with a need to improve on current treatment approaches. Targeting sphingosine …

Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes

TM Nguyen, M Jambhrunkar, SS Wong… - Molecular …, 2023 - research.sahmri.org.au
Acute myeloid leukemia (AML) kills 75% of patients and represents a major clinical
challenge with a need to improve on current treatment approaches. Targeting sphingosine …

Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes.

TM Nguyen, M Jambhrunkar, SS Wong, DM Ross… - 2023 - digital.library.adelaide.edu.au
Acute myeloid leukemia (AML) kills 75% of patients and represents a major clinical
challenge with a need to improve on current treatment approaches. Targeting sphingosine …